Interleukin (IL)-15 in combination with IL-2, fms-like tyrosine kinase-3 ligand and anti-CD3 significantly enhances umbilical cord blood natural killer (NK) cell and NK-cell subset expansion and NK function

Prakash SatwaniDepartment of Pediatrics, Columbia University, New York, New York, USA

Carmella van de VenDepartment of Pediatrics, Columbia University, New York, New York, USA

Janet AyelloDepartment of Pediatrics, Columbia University, New York, New York, USA

Dustin CairoDepartment of Pediatrics, Columbia University, New York, New York, USA

Lynn L. SimpsonDepartment of Obstetrics and Gynecology, Columbia University, New York, New York, USA

Laxmi BaxiDepartment of Obstetrics and Gynecology, Columbia University, New York, New York, USA

Mitchell S. CairoDepartment of Pediatrics, Columbia University, New York, New York, USA;Department of Medicine, Columbia University, New York, New York, USA;Department of Pathology and Cell Biology, Columbia University, New York, New York, USACorrespondence[email protected]

show all

Interleukin (IL)-15 in combination with IL-2, fms-like tyrosine kinase-3 ligand and anti-CD3 significantly enhances umbilical cord blood natural killer (NK) cell and NK-cell subset expansion and NK function

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Interleukin (IL)-15 in combination with IL-2, fms-like tyrosine kinase-3 ligand and anti-CD3 significantly enhances umbilical cord blood natural killer (NK) cell and NK-cell subset expansion and NK function

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date